| Serial Number | 90747125 |
| Word Mark | SYNOX THERAPEUTICS |
| Filing Date | Tuesday, June 1, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 13, 2022 |
| Registration Number | 6920982 |
| Registration Date | Tuesday, December 13, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 27, 2022 |
| Description of Mark | The mark consists of large lowercase and uppercase letters spelling "SynOx" above the word "Therapeutics" in a smaller font below and to the right hand side, inside 3 imperfect circles. |
| Goods and Services | Humanised antibody-based drugs for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, namely, humanised antibody emactuzumab targeting the CSF1R (colony stimulating factor 1 receptor) in cancer for the treatment of cancer and inflammatory diseases; pharmaceutical products, namely, inhibitors of CSF1R and macrophage function for the treatment of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, namely, inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of TGCT (tenosynovial giant cell tumour)/PVNS (pigmented villonodular synovitis); pharmaceutical compounds for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases |
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 25, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SynOx Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Dublin D02KC57 IE |
| Party Name | SynOx Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Dublin D02KC57 IE |
| Party Name | SynOx Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Dublin D02KC57 IE |
| Event Date | Event Description |
| Tuesday, December 13, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, December 13, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 27, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 27, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 7, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 23, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 12, 2022 | ASSIGNED TO LIE |
| Tuesday, July 19, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 22, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 22, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 22, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 15, 2022 | ASSIGNED TO EXAMINER |
| Thursday, August 26, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, August 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, June 4, 2021 | NEW APPLICATION ENTERED IN TRAM |